middle.news
How Will EVE’s Nextract Acquisition Disrupt the $5.3B Erectile Dysfunction Market?
9:55am on Thursday 12th of June, 2025 AEST
•
Healthcare
Read Story
How Will EVE’s Nextract Acquisition Disrupt the $5.3B Erectile Dysfunction Market?
9:55am on Thursday 12th of June, 2025 AEST
Key Points
Acquisition of Nextract completed via share issuance
Lead product targets $5.3 billion erectile dysfunction market
Second product in development for $10.9 billion dysmenorrhea market
$1 million placement and $500,000 Share Purchase Plan to fund growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Eve Health (ASX:EVE)
OPEN ARTICLE